Label-Free Screening of SARS-CoV-2 NSP14 Exonuclease Activity Using SAMDI Mass Spectrometry
Open Access
- 1 July 2021
- journal article
- research article
- Published by Elsevier in SLAS Discovery
- Vol. 26 (6) , 766-774
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- A Mass Spectrometric Assay of METTL3/METTL14 Methyltransferase ActivitySLAS Discovery, 2020
- Using Peptide Arrays to Profile Phosphatase Activity in Cell LysatesChemistry – A European Journal, 2019
- Traceless Immobilization of Analytes for High-Throughput Experiments with SAMDI Mass SpectrometryJournal of the American Chemical Society, 2018
- Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading ExoribonucleasemBio, 2018
- Identification of Small-Molecule Noncovalent Binders Utilizing SAMDI TechnologySLAS Discovery, 2017
- A High-Throughput Mass Spectrometry Assay Coupled with Redox Activity Testing Reduces Artifacts and False Positives in Lysine Demethylase ScreeningSLAS Discovery, 2015
- Profiling Deacetylase Activities in Cell Lysates with Peptide Arrays and SAMDI Mass SpectrometryAnalytical Chemistry, 2013
- Infidelity of SARS-CoV Nsp14-Exonuclease Mutant Virus Replication Is Revealed by Complete Genome SequencingPLOS Pathogens, 2010
- The substrate specificity of SARS coronavirus 3C-like proteinaseBiochemical and Biophysical Research Communications, 2005
- A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening AssaysSLAS Discovery, 1999